Upcoming Conference Call for Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) has recently announced an upcoming conference call dedicated to discussing its financial results for the first quarter of fiscal year 2025. This important event is set for a morning slot to ensure that all stakeholders can participate and gain insights into the company's performance.
Details of the Conference Call
Date and Time
The conference call is scheduled for a Wednesday morning at 8:00 a.m. CDT. Joining the call is straightforward, with dial-in options available for both domestic and international callers, ensuring everyone has access to this vital discussion.
How to Participate
Participants can dial in to the conference using either 1-877-407-9208 or 1-201-493-6784. For those unable to join the live call, a rebroadcast will be available to accommodate all interested parties.
Accessing the Webcast
In addition to the dial-in option, there will also be a webcast available for those who prefer it. Access the webcast via Bio-Techne's investor relations website to stay updated on the company's narrative and fiscal strategies.
Bio-Techne's Focus on Innovation
Bio-Techne Corporation, a leading name in life sciences, focuses on providing innovative tools and bioactive reagents. These products are crucial for the research and clinical diagnostics sectors. They support scientific inquiries into biological mechanisms and the advancement of understanding various diseases.
Financial Performance Overview
For the past fiscal year, Bio-Techne reported net sales of around $1.2 billion. This demonstrates a strong market standing, aligned with their commitment to advancing medical research and diagnostics capabilities.
Employee Contributions
The company boasts approximately 3,100 employees worldwide, all of whom contribute to its mission of innovating life sciences tools that aid in drug discovery and clinical testing.
Contact Information
Should you have any queries regarding the conference call or Bio-Techne's offerings, please reach out to David Clair, Vice President of Investor Relations & Corporate Development, at 612-656-4416. Diving into the details surrounding the company's progress and strategies is essential for investors and interested parties alike.
Frequently Asked Questions
What is the purpose of the conference call?
The conference call aims to disclose Bio-Techne's first quarter fiscal 2025 financial performance and discuss future strategies.
How can I listen to the conference call?
You can join the conference call by dialing the provided numbers or by accessing the webcast through Bio-Techne's investor relations webpage.
What financial results will be discussed?
The call will cover various financial metrics and performance indicators for the first quarter of fiscal year 2025.
Will there be a replay available?
Yes, a recorded replay will be available after the live event for those who cannot attend. Dial-in numbers will be provided during the call for easy access.
Who can I contact for investor relations inquiries?
David Clair is the contact person for investor relations at Bio-Techne, reachable at 612-656-4416.